Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes
Circulation - United States
doi 10.1161/01.cir.101.4.366
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2000
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)